JANE STREET GROUP, LLC

Position in FBIO — Fortress Biotech, Inc.

CIK 1595888 NEW YORK, NY

Back to FBIO Full portfolio

Position in FBIO

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$114,205

-$222,218 QoQ

Shares Held

40,934

-55.5% QoQ

Ownership

0.112%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in FBIO Over Time

Shares Held

Position Value (USD)

Derivatives in FBIO

reported options exposure · as of Dec 31, 2025

CallValue

CallShares

PutValue

$62,952

PutShares

17,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,248,975,671 across 317 Biotechnology names. FBIO ranks #247 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,757,672	$130,524,721
2	RPRX	Royalty Pharma plc	2,400,382	$115,146,324
3	TGTX	Tg Therapeutics, Inc.	2,041,669	$67,824,242
4	VRTX	Vertex Pharmaceuticals Inc / Ma	122,946	$54,900,305
5	HALO	Halozyme Therapeutics, Inc.	831,707	$53,753,223
6	EXEL	Exelixis, Inc.	1,087,030	$46,622,715
7	JAZZ	Jazz Pharmaceuticals plc	223,615	$42,274,415
8	BNTX	BioNTech SE	336,757	$29,930,962

All Filings in FBIO

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$114,205	40,934	-55.5%	Shares	Defined	2026-05-12
2025-12-31	$336,423	91,919	+434.4%	Shares	Defined	2026-02-12
2025-12-31	$62,952	17,200	-76.5%	Put	Defined	2026-02-12
2025-09-30	$270,461	73,098	+114.0%	Shares	Defined	2025-11-14
2024-12-31	$69,342	34,159	+21.3%	Shares	Defined	2025-02-14
2023-12-31	$84,758	28,159	—	Shares	Defined	2024-02-15
No filing history on record for this holder in this stock.